Tenet Healthcare Corporation (THC) Shares Sold by UBS Asset Management Americas Inc.
UBS Asset Management Americas Inc. reduced its position in Tenet Healthcare Corporation (NYSE:THC) by 8.4% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 747,808 shares of the company’s stock after selling 68,608 shares during the period. UBS Asset Management Americas Inc. owned 0.74% of Tenet Healthcare Corporation worth $14,463,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of THC. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Tenet Healthcare Corporation by 0.6% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 11,737 shares of the company’s stock valued at $227,000 after purchasing an additional 73 shares during the period. Meeder Asset Management Inc. grew its stake in Tenet Healthcare Corporation by 0.3% during the 2nd quarter. Meeder Asset Management Inc. now owns 51,741 shares of the company’s stock worth $1,001,000 after buying an additional 175 shares during the last quarter. Advantus Capital Management Inc grew its stake in Tenet Healthcare Corporation by 3.2% during the 1st quarter. Advantus Capital Management Inc now owns 10,223 shares of the company’s stock worth $181,000 after buying an additional 317 shares during the last quarter. Mason Street Advisors LLC grew its stake in Tenet Healthcare Corporation by 1.4% during the 1st quarter. Mason Street Advisors LLC now owns 37,723 shares of the company’s stock worth $668,000 after buying an additional 521 shares during the last quarter. Finally, Retirement Systems of Alabama grew its stake in Tenet Healthcare Corporation by 0.6% during the 2nd quarter. Retirement Systems of Alabama now owns 103,679 shares of the company’s stock worth $2,005,000 after buying an additional 591 shares during the last quarter.
Several research firms have commented on THC. Mizuho reaffirmed a “neutral” rating and set a $14.00 price target on shares of Tenet Healthcare Corporation in a research report on Thursday, September 14th. Jefferies Group LLC reiterated a “buy” rating and issued a $24.00 price objective (down previously from $26.00) on shares of Tenet Healthcare Corporation in a research note on Tuesday, August 8th. Credit Suisse Group decreased their price objective on Tenet Healthcare Corporation from $20.00 to $17.00 and set a “neutral” rating for the company in a report on Wednesday, August 9th. Deutsche Bank AG reissued a “buy” rating and issued a $24.00 price objective (down from $28.00) on shares of Tenet Healthcare Corporation in a report on Thursday, August 10th. Finally, Leerink Swann restated an “outperform” rating and set a $30.00 target price (up from $23.00) on shares of Tenet Healthcare Corporation in a research report on Sunday, August 20th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and six have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $21.00.
ILLEGAL ACTIVITY NOTICE: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/10/04/tenet-healthcare-corporation-thc-shares-sold-by-ubs-asset-management-americas-inc.html.
Tenet Healthcare Corporation (NYSE:THC) opened at 16.52 on Wednesday. Tenet Healthcare Corporation has a 52 week low of $12.54 and a 52 week high of $24.13. The firm’s market capitalization is $1.67 billion. The stock’s 50 day moving average is $16.18 and its 200-day moving average is $17.22.
Tenet Healthcare Corporation (NYSE:THC) last released its quarterly earnings data on Monday, August 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.17). The business had revenue of $14.80 billion during the quarter, compared to analyst estimates of $4.90 billion. Tenet Healthcare Corporation had a negative return on equity of 2.00% and a negative net margin of 0.97%. The business’s revenue for the quarter was up 204.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.38 EPS. On average, equities research analysts expect that Tenet Healthcare Corporation will post $0.80 EPS for the current year.
Tenet Healthcare Corporation Profile
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.
Receive News & Stock Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related stocks with our FREE daily email newsletter.